Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 2, 1996, Pages 127-139

  Vandamme, Anne Mieke ^a   Schmit, Jean Claude ^a   Van Dooren, Sonia ^a   Van Laethem, Kristel ^a   Gobbers, Erik ^b   Kok, Wessel ^b   Goubau, Patrick ^a   Witvrouw, Myriam ^a   Peetermans, Willy ^a   De Clercq, Erik ^a   Desmyter, Jan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Organon Teknika   (Netherlands)

Author keywords

Amplicor; HIV 1; NASBA; RNA PCR; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; RNA PROBE; RNA SEQUENCE; VIRUS CHARACTERIZATION; VIRUS DETECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1542533854     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199610010-00003     Document Type: Article

References (37)

1. Ruffault A, Michelet C, Jacquelinet C, et al. The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study. J AIDS Hum Retrovirol 1995;9:243-8.
2. Piatak M Jr., Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
3. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
4. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
5. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.
6. Urdea MS, Wilber JC, Yeghiazaria T, et al. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 1993;7(suppl 2):S11-4.
7. van Gemen B, Van Beuningen R, Nabbe A, et al. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labeled probes. J Virol Methods 1994;49:157-68.
8. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32(2):292-300.
9. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224(4648):497-500.
10. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hygiene 1938;27:493-7.
11. De Leys R, Vanderborght B, Vanden Haesevelde M, et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-16.
12. Vanden Haesevelde M, Decourt J-L, De Leys RJ, et al. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994;68(3):1586-96.
13. van Gemen B, Kievits T, Schukkink R, et al. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J Virol Methods 1993;43:177-87.
14. Vandamme A-M, Van Dooren S, Kok W, et al. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods 1995;52:121-32.
15. Whetsell AJ, Drew JB, Milman G, et al. Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1. J Clin Microbiol 1992;30:845-53.
16. McCutchan FE, Ungar BLP, Hegerich P, et al. Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1. J Acquir Immune Defic Syndr 1992;5:441-9.
17. Ansorge W, Kristensen T, Sproat B, Voss H. DNA sequencing: advanced approaches, automated methods and analysis. EMBO Practical Course manual, Heidelberg: EMBL, 1993.
18. Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine. J Virol 1992;66(12):7128-35.
19. Larder BA, Kellam P, Kemp SD. Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 1991;5:137-44.
20. Schmit J-C, Cogniaux J, Hermans P, et al. Multiple drug resistance to nucleoside analogues and non-nucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain. J Infect Dis. (in press).
21. Felsenstein J. PHYLIP - phylogeny inference package (Version 3.2). Cladistics 1989;5:164-6.
22. Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-20.
23. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phologenetic trees. Mol Biol Evol 1987;4:406-25.
24. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985;39:783-91.
25. Zharkikh A, Li W-H. Statistical properties of bootstrap estimation of phylogenetic variability from nucleotide sequences. I. Four taxa with a molecular clock. Mol Biol Evol 1992;9:119-47.
26. Layne SP, Merges MJ, Dembo M, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992;189:695-714.
27. Lu W, Andrieu J-M. Use of the human immunodeficiency virus virion as a universal standard for viral RNA quantitation by reverse transcription-linked polymerase chain reaction. J Infect Dis 1993;167:1498-9.
28. Vandamme A-M, Fransen K, Debaisieux L, et al. Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. J Virol Methods 1995;51:305-16.
29. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN, (eds). Human retroviruses and AIDS 1994. Los Alamos HIV Sequence Database 1994.
30. Kwok S, Kellogg DE, McKinney N, et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acid Res 1990;18(4):999-1005.
31. Todd J, Yeghiazarian T, Hoo B, et al. Quantitation of human immunodeficiency virus plasma RNA by branched DNA and reverse transcription coupled polymerase chain reaction assay methods: a critical evaluation of accuracy and reproducibility. Serodiagn Immunother Infect Dis 1994;6(4):233-9.
32. Pachl C, Todd AJ, Kern DG, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:446-54.
33. Kaye S, Comber E, Tenant-Flowers M, Loveday C. The appearance of drug-resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA. AIDS Res Hum Retrovir 1995;11:(10):1221-5.
34. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type I in human plasma. AIDS Res Hum Retrovir 1995;11(3):353-61.
35. Holodniy M, Katzenstein DA, Sengupta S, et al. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis 1991;163:862-6.
36. Mole L, Margolis D, Carroll R, Todd H, Holodniy M. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA and p24 antigen from samples collected in vacutainer CPT and standard vacutainer tubes. J Clin Microbiol 1994;32:2212-15.
37. Coombs RW, Henrard DR, Mehaffey WF, et al. Cell-free plasma human immunodeficiency virus type I titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol 1993;31(8):1980-6.